Etodolac injection - Ipca Laboratories

Drug Profile

Etodolac injection - Ipca Laboratories

Alternative Names: Etova-AQ; MACRE-09

Latest Information Update: 04 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ipca Laboratories
  • Class Antirheumatics; Indoleacetic acids; Indoles; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Postoperative pain

Most Recent Events

  • 04 May 2017 Ipca Laboratories plans a phase IV trial for Postoperative pain in India (CTRI2017-03-008275)
  • 15 Mar 2016 Biomarkers information updated
  • 15 Nov 2011 Ipca Laboratories completes a phase III trial in Post-operative pain in India (CTRI-2010-091-000437)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top